| Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue | Frank Vinluan | 09/09/20 | National |
| Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More | Frank Vinluan | 03/27/20 | National |
| Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More | Sarah de Crescenzo | 03/06/20 | National |
| ASH 2018: Three Up, Two Down as Big Blood Disease Meeting Rolls On | Ben Fidler | 12/03/18 | National |
| Bio Roundup: Not-BIO Party Foul, CRISPR Drama, Sickle Cell Updates | Ben Fidler | 06/15/18 | National |
| Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks | Ben Fidler | 03/23/18 | National |
| To Infinity and Beyond: Julian Adams on Missteps and His New Job | Ben Fidler | 04/03/17 | Boston |
| Infinity Closes Research Ops as Blood Cancer Drug Comes Up Short | Ben Fidler | 06/14/16 | Boston |
| West Coast Biotech Roundup: Global Blood, Invitae, GeneWEAVE, Adynxx | Alex Lash | 08/13/15 | San Francisco |
